U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 71 - 80 of 83

Drug Safety Communications - FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Families
Communities
Source
U.S. Food & Drug Administration (FDA)
Year
Resource Type
Web Page

Matrix Intensive Outpatient Treatment for People With Stimulant Use Disorders: Client's Handbook

Contains handouts that clients will need for treatment. Includes handouts for three types of sessions: Individual/ Conjoint, Early Recovery Skills, and Relapse Prevention.
Format
Guide
Audience
Patients
Families
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF
File Size
1.15 MB

Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use

This guideline updates the state of the science on pain research, care, and education with a particular focus on informing the Food and Drug Administration's (FDA's) development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Format
Guide
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Policymakers and Payers
Source
The National Academies of Sciences, Engineering, and Medicine
Year
Resource Type
PDF
File Size
11.2 MB

The Role of a Prescription Drug Monitoring Program in Reducing Prescription Drug Diversion, Misuse, and Abuse

Provides facts about the benefits of using PDMPs for prescribers, pharmacists, patients, and regulatory and law enforcement agencies.

Format
Fact Sheet/Brochure
Audience
Communities
Medical Providers
Other Team Members
Patients
Policymakers and Payers
States
Source
Centers for Medicare & Medicaid Services
Year
File Size
.32 MB

Drug Diversion Toolkit: Buprenorphine — A Primer for Prescribers and Pharmacists

Provides guidance to physicians and pharmacists on buprenorphine regulatory requirements, prescribing, dispensing, and safety recommendations and additional information to improve decision making and promote beneficial outcomes.
Link
https://www.homestatehealth.com/content/dam/centene/home-state-health/pdfs/drugdiversion-buprenorphine-booklet.pdf
Format
Toolkit
Audience
Medical Providers
Other Team Members
Source
Centers for Medicare & Medicaid Services
Year

Matrix Intensive Outpatient Treatment for People With Stimulant Use Disorders: Client's Treatment Companion

A book for clients to record ideas and reminders that will strengthen their recovery and help them stay abstinent.
Format
Guide
Audience
Patients
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF
File Size
486 KB

Matrix Intensive Outpatient Treatment for People With Stimulant Use Disorders: Counselor's Treatment Manual

This manual contains all the materials necessary for a counselor to conduct individual and group sessions using the Matrix Intensive Outpatient Treatment for People with Stimulant Use Disorders (IOP) approach.

Format
Guide
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF
File Size
2.3 MB

Counselor’s Family Education Manual: Matrix Intensive Outpatient Treatment for People With Stimulant Use Disorders

This manual provides counselors with an overview of the Family Education component of the Matrix Intensive Outpatient Treatment for People with Stimulant Use Disorders (IOP) package and general guidelines for conducting sessions.

Format
Guide
Audience
Behavioral Health Providers
Families
Medical Providers
Other Team Members
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF
File Size
1.07 MB